stockrowActinium Pharmaceuticals, Inc. (ATNM) vs Sangamo Therapeutics, Inc. (SGMOQ)
- Actinium Pharmaceuticals, Inc. ATNM 1.42 +9.23%
- Sangamo Therapeutics, Inc. SGMOQ 0.11 0.00%
Actinium Pharmaceuticals, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. Actinium Pharmaceuticals, Inc. and Sangamo Therapeutics, Inc. are of similar size ($41.9M and $40.9M). Sangamo Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Actinium Pharmaceuticals, Inc. trades at 3.9×. Actinium Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 2,731.2% against −45.8%. Actinium Pharmaceuticals, Inc. has the higher net margin (32.2% vs −356.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Actinium Pharmaceuticals, Inc. leads on 10 and Sangamo Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ATNM | SGMOQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.71% | 100.00% | 68.51% |
| Operating margin | 27.20% | (357.55%) | 0.00% |
| Net margin | 32.18% | (356.89%) | 0.00% |
| Free cash flow margin | (66.16%) | (261.76%) | 0.00% |
| Return on equity | 45.86% | 1,755.72% | (51.96%) |
| Return on assets | 21.92% | (168.79%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack